ReviewCurrent medicinal chemistry2025

A Perspective of PI3K/AKT/mTOR Pathway Inhibitors to Overcome Drug-resistance in Breast Cancer Therapy.

Sudip Kumar Mandal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.